Canopy Growth Corp. Stock Prices This tracks Canada's largest medical marijuana company's stock prices.
Healthcare
XLV ShortYou can thank that little price hiking hedge fund manager and people like Bill Ackman for the Healthcare/Pharmaceutical correction. Looking at the weekly using Fibs as reference points i believe healthcare over the next few months will begin to sell. I have a target of the 1.618 extension of 59.76 and a second target of 53.31. I'm using XLV to short because everything else is too expensive... you can play this through ITM puts or buy a longterm out of the money put at a 62 or 60 strike for next year.
Feel free to leave comments or questions.
-Ryanhasoptions.
Johnson & Johnson vs USDJohnson & Johnson has seen extreme price consolidation since last November. Since they are a highly diversified healthcare company, currency translations affect their bottom line quite substantially. With the recent contraction of the US Dollar, Johnson & Johnson has broken out of a prolonged trading range. If the dollar continues to contract against other foreign currencies, Johnson & Johnson will make better on their hedges and increase the bottom line substantially, thus increasing free cash flow and overall economic opportunity.
On Break LongXLV could move nicely as the healthcare stocks continue to advance, watch for a breakout with volume to take the trade and stop 8% down
Almost Family Does 38.2% RetracementAlmost Family has done a 38.2% Fibonacci Retracement.
Almost Family has grown EPS by +1340% quarter over quarter, and EPS forecasts for this company are rising fast.
This company has had an EPS surprise for the last 8 quarters!
The company has an excellent P/S of 0.8.
The catalyst for growth is that Americans are living longer and that means more home health care services are needed.
According to a 2014 report by Transparency Market Research, the global home health care market is expected to explode to $303.6 billion in 2020, up from $176.1 billion in 2013, growing at a compound rate of more than 8% per year.
Source: www.guerillastocktrading.com
Risk Averse Market - 2015 First and Second quartersWhat I am not showing here is, that the Cyclicals are losing steam, Sensitive Market is in neutral trend, Defensive has been the buyers paradise since OCT 2014.
Why I think that this can be called as a Biotech Bubble is because, It has done the same exact thing Financials did in 2007. ie., Moved tooo quick tooo far.
Yes Bio Tech (Healthcare) sector is a defensive sector, but this is not "the normal" on a defensive sector.
What could fuel this bubble burst ? That's up to the Govt, and the Medical Insurances out there. Most Medical Insurance at this point is so frustrated with the high Drug / Healthcare provider prices.
////////////////////
Note : This is not a Doom and Gloom Idea to trade. Its just my opinion - I am personally taking cautious actions with the market, that is reducing the risk to 1% or under in a trade. And focus on the Strong and Weak Sectors, Rather than the mixed bag.
This may not happen until second quarter of 2015, or even mid 2015. While the trend is up, I am still bullish. Until there is a transition.
Related Ideas - Show how trend changes again IMO.
Weekly Cup and Handle showing promiseA cup and handle pattern can result in strong price movement. Enter a small position and scale in if volume continues to follow through.
Long Mckesson CorpThe Healthcare Providers industry is one of the top performing industries in the strongest Sector in the S&P500, Healthcare. McKesson Corp is in a clear uptrend and has been gaining momentum as the relative performance chart indicates it has been ourperfoming the S&P more and more.
The recent Bollinger Squeeze on the Weekly chart suggests there could be a breakout to new highs. Any break of the uptrend should be an exit signal as the stock may start correcting.
